Congressional record
C. Franklin bought Amgen Inc. stock on AUG 7, 2024.
C. Franklin — a trade near an FDA decision
The FDA approved a product from Amgen Inc. on AUG 6, 2024.
1 day separated the trade and the FDA action.
6 of Franklin's disclosed trades fall within three weeks of an FDA decision.
Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
SOURCE: STOCK ACT DISCLOSURES, HOUSE CLERK · OPENFDA, U.S. FOOD & DRUG ADMINISTRATION